Chemclin Diagnostics Past Earnings Performance
Past criteria checks 2/6
Chemclin Diagnostics has been growing earnings at an average annual rate of 2.7%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been declining at an average rate of 3.2% per year. Chemclin Diagnostics's return on equity is 10.9%, and it has net margins of 33.1%.
Key information
2.7%
Earnings growth rate
-9.9%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | -3.2% |
| Return on equity | 10.9% |
| Net Margin | 33.1% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses BreakdownBeta
How Chemclin Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 456 | 151 | 139 | 67 |
| 31 Dec 23 | 445 | 147 | 133 | 66 |
| 30 Sep 23 | 438 | 146 | 65 | 33 |
| 30 Jun 23 | 461 | 160 | 134 | 68 |
| 31 Mar 23 | 445 | 148 | 129 | 67 |
| 31 Dec 22 | 465 | 153 | 135 | 68 |
| 30 Sep 22 | 475 | 153 | 136 | 70 |
| 30 Jun 22 | 457 | 142 | 136 | 68 |
| 31 Mar 22 | 471 | 144 | 142 | 71 |
| 31 Dec 21 | 471 | 143 | 143 | 67 |
| 30 Sep 21 | 478 | 148 | 149 | 59 |
| 30 Jun 21 | 504 | 156 | 148 | 64 |
| 31 Mar 21 | 479 | 144 | 139 | 58 |
| 31 Dec 20 | 418 | 117 | 129 | 54 |
| 31 Dec 19 | 455 | 141 | 141 | 55 |
| 31 Dec 18 | 366 | -424 | 633 | 50 |
| 31 Dec 17 | 319 | -435 | 621 | 31 |
Quality Earnings: 688468 has a high level of non-cash earnings.
Growing Profit Margin: 688468's current net profit margins (33.1%) are lower than last year (33.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688468 has become profitable over the past 5 years, growing earnings by 2.7% per year.
Accelerating Growth: 688468's earnings growth over the past year (1.7%) is below its 5-year average (2.7% per year).
Earnings vs Industry: 688468 earnings growth over the past year (1.7%) exceeded the Medical Equipment industry -1.3%.
Return on Equity
High ROE: 688468's Return on Equity (10.9%) is considered low.